secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mosaic ImmunoEngineering Inc. (CPMV)
CIK:        0000836564
Form:       8-K
Filed at:   2025-01-02T23:59:59+00:00
Accession:  0001683168-25-000009
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mosaic ImmunoEngineering extends Oncotelic acquisition term sheet to June 30, 2025
--------------------------------------------------------------------------------

- Binding term sheet for acquisition of Oncotelic's necroptosis cancer therapies and AI tech extended to June 30, 2025.
- Original deal: $15M stock issuance at closing plus up to $15M milestone shares.
- Extension allows more time for due diligence and drafting definitive agreements; no guarantee a deal will close.
- Parties continue negotiating; prior expiration was December 31, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/836564/000168316825000009/0001683168-25-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/836564/000168316825000009/mosaic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer